Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016826
Chunk: 62

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 62
---
 in respect of such securities
and property; and (ii) in the event the depositary or its custodian receives a distribution other than cash, our Ordinary Shares and/or
rights to acquire our Ordinary Shares, and such distribution consists of securities or property that are not distributed by the depositary
the depositary will be deemed to have sold the aggregate number of securities and/or property so received for nominal value and shall
have no obligation to distribute such securities or any proceeds from the deemed sale thereof to the ADR holders. Furthermore, in the
event the depositary endeavors to make a sale of Ordinary Shares, other securities or property, such securities and/or property may be
sold in a block sale or single lot transaction.

Except as stated below, the
depositary will deliver such distributions to ADR holders in proportion to their interests in the following manner:

| · | Cash.                                                                                           
 The depositary will distribute any U.S. dollars available to it resulting from a cash dividend  
 or other cash distribution or the net proceeds of sales of any other distribution or portion    
 thereof (to the extent applicable), on an averaged or other practicable basis, subject to       
 (i) appropriate adjustments for taxes withheld, (ii) such distribution being permissible        
 or practicable with respect to certain registered ADR holders, and (iii) deduction of the       
 depositary’s and/or its agents’ fees and expenses in (1) converting any foreign                 
 currency to U.S. dollars to the extent that it determines that such conversion may be made      
 on a reasonable basis, (2) transferring foreign currency or U.S. dollars to the United States   
 by such means as the depositary may determine to the extent that it determines that such        
 transfer may be made on a reasonable basis, (3) obtaining any approval or license of any        
 governmental authority required for such conversion or transfer, which is obtainable at a       
 reasonable cost and within a reasonable time and (4) making any sale by public or private       
 means in any commercially reasonable manner. To the extent that any of the deposited securities 
 is not or shall not be entitled, by reason of its date of issuance, or otherwise, to receive    
 the full amount of such cash dividend, distribution, or net proceeds of sales, the depositary   
 shall make appropriate adjustments in the amounts distributed to the ADR holders issued in      
 respect of such deposited securities. To the extent we or the depositary shall be required      
 to withhold and do withhold from any cash dividend, distribution or net proceeds